Lantheus Holdings, Inc. (LNTH) Social Stream



Lantheus Holdings, Inc. (LNTH): $58.85

0.40 (+0.68%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

LANTHEUS HOLDINGS INC (LNTH) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering LANTHEUS HOLDINGS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-21 2 $40 $34 $37 $59.69 -38.01%
2022-01-24 2 $40.001 $34 $37 $59.69 -38.01%
2022-02-24 2 $75 $55 $65 $59.69 8.9%
2022-03-14 2 $75 $60 $67.5 $59.69 13.08%
2022-04-13 3 $77 $60 $70.666 $59.69 18.39%
2022-05-02 3 $100 $80 $91.333 $59.69 53.01%
2022-06-08 4 $100 $80 $91.25 $59.69 52.87%
2022-07-18 3 $100.001 $80 $91.333 $59.69 53.01%
2022-08-05 3 $110 $100 $103.333 $59.69 73.12%
2022-08-25 4 $110 $100 $103 $59.69 72.56%
2022-11-04 5 $110 $100 $103.4 $59.69 73.23%

The Trend in the Analyst Price Target


Over the past 30 months, LNTH's average price target has gone up $84.73.

Over the past 45 weeks, LNTH's average upside potential has been 39.65%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-01-06 2 40.001 34 37.00 27.62 33.96%
2022-03-14 3 75.000 60 67.50 49.87 35.35%
2022-05-13 4 100.000 80 91.25 64.00 42.58%
2022-10-13 5 110.000 100 103.40 70.94 45.76%
2022-10-24 5 110.000 100 103.40 72.47 42.68%

LNTH Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


Over the past 29 months, LNTH's average broker recommendation rating improved by 0.67.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • LNTH has a higher number of analysts covering the stock than 179.58% of all US stocks.
  • In the context of Pharmaceutical Products stocks, LANTHEUS HOLDINGS INC's variance in analysts' estimates is lower than -73.14% of them.
  • In terms of how LANTHEUS HOLDINGS INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is higher than 1199.49% of that group.
  • LANTHEUS HOLDINGS INC's upside potential (average analyst target price relative to current price) is higher than 302.3% of Pharmaceutical Products stocks.

Stocks similar to LANTHEUS HOLDINGS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RIOT, MYGN, and NEOG.

What is the outlook for LNTH? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6754 seconds.